Concepedia

Author

Timothy J. Hartingh

United States Military Academy

Also Known As

Timothy Hartingh, Timothy J. Hartingh

10

Publications

212

Citations

7

H-Index

14

Concepts

All Affiliations

United States Military AcademyMerck & Co., Inc., Rahway, NJ, USA (United States)Merck Canada Inc. (Canada)
TJ

About

Timothy J. Hartingh is an author at United States Military Academy specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

145

2

Biochemistry

4

4

136

3

Natural Sciences

2

2

110

4

Chemical Biology

2

2

59

5

Biomolecular Engineering

1

1

23

Timothy J. Hartingh

×

6

Publications

195

Citations

6

H-Index

YearCitations

Development of thioquinazolinones, allosteric Chk1 kinase inhibitors

Antonella Converso, Timothy J. Hartingh, R. M. Garbaccio,

Bioorganic & Medicinal Chemistry Letters

2008

74

Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors

Izzat T. Raheem, Abbas M. Walji, Daniel J. Klein,

Journal of Medicinal Chemistry

2015

36

Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia

M. E. Layton, Jeffrey C. Kern, Timothy J. Hartingh,

Journal of Medicinal Chemistry

2023

36

Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic

Valerie W. Shurtleff, M. E. Layton, Craig A. Parish,

Journal of Medicinal Chemistry

2024

23

Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolase

Antonella Converso, Timothy J. Hartingh, Mark E. Fraley,

Bioorganic & Medicinal Chemistry Letters

2014

14

Discovery and optimization of 2-pyridinone aminal integrase strand transfer inhibitors for the treatment of HIV

John D. Schreier, Mark W. Embrey, Izzat T. Raheem,

Bioorganic & Medicinal Chemistry Letters

2017

12

Page 1